Skip to main navigation Skip to search Skip to main content

The cardiometabolic safety of interleukin 23 versus interleukin 17 inhibitors in psoriasis: A large-scale global cohort study

  • University of Lübeck
  • Padeh Medical Center
  • University Hospital Schleswig-Holstein

Research output: Contribution to journalLetterpeer-review

7 Scopus citations
Original languageEnglish
Pages (from-to)e683-e685
JournalJournal of the European Academy of Dermatology and Venereology
Volume37
Issue number5
DOIs
StatePublished - May 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this